Introduction {#sec1}
============

Owing to their unique biological, physical, and chemical properties, fluoroalkylated organic substances are of great importance in a variety of disciplines.^[@ref1]^ Among these compounds, molecules containing a difluoromethyl group (RCF~2~−) are especially desirable building blocks for use in medicinal chemistry because of their superior lipophilicity, binding selectivity, and metabolic stability. Several efficient methods for introducing the difluoromethyl unit into organic molecules have been reported:^[@ref2]^ one of these methods involves the use of a metal difluorinating reagent, including copper,^[@ref3]^ silver,^[@ref4]^ tin reagents,^[@ref5]^ and so on. Difluoromethyl carboxylic acid skeletons (CF~2~CONR^1^R^2^, CF~2~CO~2~Et, and CF~2~PO(OEt)~2~), which serve as another source of the difluoromethyl group, have attracted considerable attention because they are readily available and can be easily transformed into other fluorine-containing groups.^[@ref6]^

Chromones are important moieties found in natural products and pharmaceuticals;^[@ref7]^ a number of approaches for the synthesis of their derivatives, especially for the synthesis of C3-functionalized analogues from *o*-hydroxyl-acetophenones by the tandem cyclization process, have been developed. These syntheses are characterized by the Baker--Venkataraman reaction, Claisen--Schmidt reaction, and Vilsmeier--Haack reaction, and so on.^[@cit7b]^ Given their importance, the development of a new, efficient method for the synthesis of 3-CF~2~-incorporated chromone derivatives is still in demand. In 2013, Yang's group reported the first synthesis of 3-CF~2~-containing chromones via palladium-catalyzed cross-coupling of ethyl bromodifluoroacetate with 3-iodochromones ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, method A),^[@cit8a]^ and very recently, Yang and Chen reported a visible-light-driven, radical-triggered tandem cyclization of *o*-hydroxyaryl enaminones ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, method B).^[@cit8b]^ However, the yield of the product under the oxidation cycle of iridium is not ideal. The synthesis of 3-CF~2~-containing chromones via a ruthenium reduction cycle may be a cheaper and an efficient method.

![Synthesis of 3-CF~2~-Containing Chromones](ao-2017-00383d_0001){#sch1}

Photoredox catalysis provides a green and sustainable synthetic method for the assembly of diverse important compounds under mild reaction conditions.^[@ref9]^ In the extensively explored synthesis of fluorinated molecules, a variety of fluorinating reagents, including BrCF~2~CO~2~R, have been used to generate CF~2~ radicals under visible light.^[@ref10]^ Herein, we report an efficient synthesis of 3-CF~2~-containing chromones via the photocatalytic radical cascade reaction of *o*-hydroxyaryl enaminones with ethyl bromodifluoroacetate in one step ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, method C).

Results and Discussion {#sec2}
======================

We have reported a ruthenium-catalyzed reaction of α-bromocarboxylates and enamines to generate γ-ketoesters under visible light. In this reaction, Et~3~N was used to reduce \[Ru(bpy)~3~\]^2+\*^ to \[Ru(bpy)~3~\]^+^; then, \[Ru(bpy)~3~\]^+^ underwent a single-electron transfer process with the C--Br bond of ethyl bromodifluoroacetate to generate an electron-deficient radical to react with enamines.^[@ref11]^ We initiated our study with (*E*)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one (**1a**) and ethyl bromodifluoroacetate, with Ru(bpy)~3~Cl~2~ (1 mol %) as the catalyst and Et~3~N (40 mol %) as the initial reducing agent under irradiation with a 45 W LED lamp, intending to develop a cascade radical addition--cyclization reaction. Fortunately, the reaction did occur at room temperature, giving the desired 3-CF~2~-containing chromone, **2a**, in 14% yield, along with two byproducts, 4*H*-chromen-4-one (**3a**, 16%) and 3-bromo-4*H*-chromen-4-one (**4a**, 6%) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). The presence of **3a** indicated a self-ring-closure reaction of **1a**, and the formation of **4a** implied the electrophilic addition reaction of **3a** with Br~2~, followed by dehydrobromination.^[@ref12]^ It is evident that the reaction will produce HBr, which may weaken the reducibility of Et~3~N and the nucleophilicity of the phenolic hydroxyl group of the substrate. To improve the efficiency of the reaction, we examined the influence of the bases, and the results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

###### Optimization of the Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-00383d_0004){#fx1}

                                                                                                    yield[b](#t1fn2){ref-type="table-fn"} (%)           
  ------------------------------------ ------------------ --------------------------- ------------- ------------------------------------------- ------- -------
  1                                    Ru(bpy)~3~Cl~2~    dimethyl sulfoxide (DMSO)                 14                                          16      6
  2                                    Ru(bpy)~3~Cl~2~    DMSO                        NaOAc         22                                          25      25
  3                                    Ru(bpy)~3~Cl~2~    DMSO                        Na~2~HPO~4~   52                                          33      trace
  4                                    Ru(bpy)~3~Cl~2~    DMSO                        NaH~2~PO~4~   trace                                       68      27
  5                                    Ru(bpy)~3~Cl~2~    DMSO                        Na~2~CO~3~    trace                                       trace   trace
  6                                    Ru(bpy)~3~Cl~2~    DMSO                        Na~2~SO~3~    76                                                   
  7                                    Ru(bpy)~3~Cl~2~    DMSO                        NaHSO~3~      81                                                   
  8                                    Ru(bpy)~3~Cl~2~    MeCN                        NaHSO~3~      trace                                       trace   trace
  9                                    Ru(bpy)~3~Cl~2~    CH~3~OH                     NaHSO~3~                                                  27       
  10                                   Ru(bpy)~3~Cl~2~    DCE                         NaHSO~3~      trace                                       trace   trace
  11                                   rhodamine          DMSO                        NaHSO~3~      trace                                                
  12                                   acid red 87        DMSO                        NaHSO~3~      trace                                                
  13                                   rose bengal        DMSO                        NaHSO~3~      74                                                   
  14                                   *fac*-Ir(ppy)~3~   DMSO                        NaHSO~3~      75                                                   
  15[c](#t1fn3){ref-type="table-fn"}   Ru(bpy)~3~Cl~2~    DMSO                        NaHSO~3~      68%                                                  
  16[d](#t1fn4){ref-type="table-fn"}   Ru(bpy)~3~Cl~2~    DMSO                        NaHSO~3~      60%                                         21%      
  17[e](#t1fn5){ref-type="table-fn"}   Ru(bpy)~3~Cl~2~    DMSO                        NaHSO~3~      60%                                                  
  18[f](#t1fn6){ref-type="table-fn"}   none               DMSO                        NaHSO~3~      0                                                    
  19[g](#t1fn7){ref-type="table-fn"}   Ru(bpy)~3~Cl~2~    DMSO                        NaHSO~3~      0                                                    

Reaction conditions: **1a** (95.61 mg, 0.5 mmol), BrCF~2~COOEt (253.73 mg, 2.5 equiv), base (1.5 equiv), Et~3~N (0.4 equiv), catalyst (1 mol %), solvent (6 mL), irradiation with a 45 W household light bulb, rt, 24 h.

Isolated yield.

Without Et~3~N.

BrCF~2~COOEt (1.5 equiv).

18 h.

Without catalyst.

Without light.

When NaOAc was used as the base, the reaction gave a better conversion and a slightly higher yield of the desired product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 2). When Na~2~HPO~4~ was used as the base, the yield was obviously improved ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3); however, when we changed the base to NaH~2~PO~4~, an almost quantitative yield of byproducts was observed instead of the desired product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). There was almost no product or byproduct observed when the stronger base Na~2~CO~3~ was used in the reaction ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 5). One can envision that the addition of a reductive base may reduce the Br~2~ possibly produced in the reaction and inhibit the production of byproduct **4a**. To our delight, some bases with a certain degree of reducibility, such as Na~2~SO~3~ and NaHSO~3~, led to a much higher yield of the desired product, with no detectable byproducts, **3a** or **4a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 6 and 7). Solvent screening proved DMSO to be more superior to other solvents in the presence of NaHSO~3~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 8--10). Further optimization of reaction conditions did not improve the yield of the product when other catalysts were investigated ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 11--14). We also conducted further study on the quantity of Et~3~N, which showed that 40% equiv Et~3~N was enough to achieve good yields, but the absence of Et~3~N resulted in a decrease in yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 15). When the amount of ethyl bromodifluoroacetate was reduced to 1.5 equiv, the yield of the desired product was decreased ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 16); when the reaction time was shortened to 18 h, only 60% of the desired product was obtained, with unreacted starting material ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 17). Besides this, control experiments showed that both Ru(bpy)~3~Cl~2~ and visible light are essential for this reaction ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 18 and 19).

With these optimized reaction conditions in hand, we explored the substrate scope with different *o*-hydroxyaryl enaminone derivatives. We were pleased to find that both the electron-withdrawing and -donating substituents on the aromatic ring of (*E*)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one were suitable substrates to obtain the target products in moderate to high yields ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, **2b**--**l**), and the reaction tolerated various functional groups, including fluoro, chloro, methyl, methoxyl, and cyano groups. It was noteworthy that the position of the substituent on the aromatic ring has a dramatic influence. The substituents at the meta position of the aromatic ring of (*E*)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one gave lower yields than those of substituents at the ortho or para position. Substrates with a methyl, methoxyl, or fluoro group at the ortho or para position afforded the corresponding 3-CF~2~-containing chromones in good yields ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}; **2b**, **2d**, **2e**, **2g**, **2j**), whereas substrates with a methyl, methoxyl, or fluoro group at the meta position gave only moderate yields ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}; **2c**, **2f**, **2i**).

###### Substrate Scope of the Reaction[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}

![](ao-2017-00383d_0005){#fx2}

Reaction conditions: **1** (0.5 mmol), BrCF~2~COOEt (2.5 equiv), base (1.5 equiv), Et~3~N (0.4 equiv), catalyst (1 mol %), solvent (6 mL), irradiation with a 45 W LED bulb, rt, 24 h.

Isolated yield.

To understand the mechanism of the reaction, two control experiments were performed ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The results of reaction (1) showed that 4*H*-chromen-4-one **3a** could not be converted to the desired product under our standard conditions, which means that the target product is not generated from the addition of chromone **3a** with ethyl bromodifluoroacetate. At the same time, when 4 equiv of TEMPO relative to **1a** was added to the reaction system, the target product was not detected, which indicates that the mechanism of the reaction is likely to be radical addition.

![Control Experiments](ao-2017-00383d_0002){#sch2}

On the basis of the above experiments, we proposed a mechanism for the formation of the desired 3-CF~2~-containing chromones under visible light ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). At first, irradiation of the catalyst \[Ru(bpy)~3~\]^2+^ under visible light generated the excited species \[Ru(bpy)~3~\]^2+\*^, which oxidized Et~3~N to form the new species \[Ru(bpy)~3~\]^1+^. The electron-rich metal complex \[Ru(bpy)~3~\]^+^ then underwent a single-electron transfer process with the C--Br bond of ethyl bromodifluoroacetate to afford an electron-deficient radical **I** and regenerate \[Ru(bpy)~3~\]^2+^. Radical **I** was added to the α-position of α, β unsaturated ketone **1a** to form radical **II**. Radical **II** also participated in the reduction of \[Ru(bpy)~3~\]^2+\*^ to generate the iminium cation intermediate **III** and form the metal complex \[Ru(bpy)~3~\]^+^, with the completion of the photoredox catalytic cycle. Hydroxyl groups on benzene rings attacked the iminium cation to give intermediate **IV**. Finally, the dimethylamine was eliminated to give the desired product.

![Proposed Mechanism](ao-2017-00383d_0003){#sch3}

Conclusions {#sec3}
===========

In summary, we have developed an efficient method for the generation of chromone derivatives by the radical addition reaction of (*E*)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one and ethyl bromodifluoroacetate under visible light. This reaction allows for the construction of chromone derivatives, which are useful synthetic intermediates and important skeletons of biologically active molecules in organic synthesis, with a broad substrate scope, under mild conditions in good to excellent yields.

Experimental Section {#sec4}
====================

General Procedures {#sec4.1}
------------------

Chemicals purchased from commercial sources were used without further purification. Anhydrous DMSO was freshly distilled from calcium hydride. ^1^H NMR and ^13^C NMR spectra were recorded on a 400 MHz spectrometer. The chemical shifts for ^1^H NMR were recorded in ppm downfield from the solvent using CDCl~3~ (for ^1^H, δ = 7.26) resonance as the internal standard. The chemical shifts for ^13^C NMR were recorded in ppm downfield using the central peak of deuterochloroform (77.16 ppm) as the internal standard. ^19^F NMR was recorded at 376 MHz using CF~3~COOH as an external standard. The abbreviations of splitting patterns are described as follows: s = singlet, d = doublet, t = triplet, q = quartet, m= multiplet, dd = doublet of doublets. HRMS was performed using the ESI ionization technique on a Q-TOF Mass Spectrometer. Flash column chromatography was performed on silica gel (300--400 mesh).

Typical Procedure for the Synthesis of *o*-Hydroxyaryl Enaminones (**1a--l**)^[@ref13]^ {#sec4.2}
---------------------------------------------------------------------------------------

A solution of 1-(2-hydroxyphenyl)ethanone (1.00 g, 7.34 mmol) and 1,1-dimethoxy-*N*,*N*-dimethylmethanamine (1.31 g, 11.02 mmol) in anhydrous xylene (6 mL) in a 25 mL flask was heated to reflux for 12 h. After the reaction was completed, the solid was precipitated by cooling the solution to room temperature and was then filtered to give the crude product. The crude product was recrystallized from EtOH to give the desired substrate.

### (*E*)-3-(Dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one (**1a**)^[@ref14]^ {#sec4.2.1}

Yellow solid, 1.20 g, 80% yield. Mp: 130.4--131.0 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 13.98 (s, 1H), 7.87 (d, *J* = 12.0 Hz, 1H), 7.69 (dd, *J* = 8.0, 1.2 Hz, 1H), 7.37--7.32 (m, 1H), 6.93 (dd, *J* = 8.0, 0.8 Hz, 1H), 6.84--6.79 (m, 1H), 5.77 (d, *J* = 12.0 Hz, 1H), 3.18 (s, 3H), 2.96 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 191.6, 163.0, 154.9, 134.1, 128.3, 120.4, 118.3, 118.1, 90.1, 45.5, 37.5.

### 3-(Dimethylamino)-1-(2-fluoro-6-hydroxyphenyl)prop-2-en-1-one (**1b**) {#sec4.2.2}

Yellow solid, 0.38 g, 64% yield. Mp: 67.4--68.9 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 14.45 (s, 1H), 7.99 (dd, *J* = 12.4, 3.2 Hz, 1H), 7.24--7.20 (m, 1H), 6.70 (d, *J* = 8.4 Hz, 1H), 6.54--6.48 (m, 1H), 5.92 (d, *J* = 12.4 Hz, 1H), 3.20 (s, 3H), 2.97 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 188.6 (d, *J* = 4.6 Hz), 164.7 (d, *J* = 5.3 Hz), 162.5 (d, *J* = 250.7 Hz), 155.7, 133.3 (d, *J* = 12.8 Hz), 114.1 (d, *J* = 3.1 Hz), 110.6 (d, *J* = 13.1 Hz), 105.6 (d, *J* = 25.6 Hz), 96.2 (d, *J* = 18.8 Hz), 45.7, 37.7. ^19^F NMR (376 MHz, CDCl~3~): δ −29.5. HRMS-ESI (*m*/*z*): Calculated for C~11~H~12~FNO~2~ (M + H)^+^: 210.0930, Found: 210.0930.

### (*E*)-3-(Dimethylamino)-1-(5-fluoro-2-hydroxyphenyl)prop-2-en-1-one (**1c**)^[@ref14]^ {#sec4.2.3}

Brown solid, 1.00 g, 69% yield. Mp: 126.4--127.7 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 13.65 (s, 1H), 7.90 (d, *J* = 12.4 Hz, 1H), 7.35 (dd, *J* = 9.6, 3.2 Hz, 1H), 7.10--7.04 (m, 1H), 6.88 (dd, *J* = 9.2, 4.8 Hz, 1H), 5.65 (d, *J* = 12.4 Hz, 1H), 3.21 (s, 3H), 2.98 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 190.4, 159.1, 154.9 (d, *J* = 234.4 Hz), 155.3, 121.2 (d, *J* = 23.2 Hz), 120.2 (d, *J* = 5.9 Hz), 119.2 (d, *J* = 7.3 Hz), 113.5 (d, *J* = 23.0 Hz), 89.9, 45.7, 37.7. ^19^F NMR (376 MHz, CDCl~3~): δ −48.1.

### (*E*)-3-(Dimethylamino)-1-(4-fluoro-2-hydroxyphenyl)prop-2-en-1-one (**1d**)^[@ref14]^ {#sec4.2.4}

Yellow solid, 1.11 g, 82% yield. Mp: 133.1--134.1 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 14.45 (s, 1H), 7.87 (d, *J* = 12.0 Hz, 1H), 7.67 (dd, *J* = 8.8, 6.8 Hz, 1H), 6.60 (dd, *J* = 10.4, 2.4 Hz, 1H), 6.54--6.48 (m, 1H), 5.66 (d, *J* = 12.0 Hz, 1H), 3.19 (s, 3H), 2.96 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 190.5, 166.2 (d, *J* = 250. 9 Hz), 165.5 (d, *J* = 13.6 Hz), 154.9, 130.3--130.2 (d, *J* = 11.3 Hz), 117.2 (d, *J* = 2.5 Hz), 106.0 (d, *J* = 22.3 Hz), 104.7 (d, *J* = 22.9 Hz), 89.8, 45.6, 37.6. ^19^F NMR (376 MHz, CDCl~3~): δ −26.6.

### (*E*)-3-(Dimethylamino)-1-(2-hydroxy-6-methoxyphenyl)prop-2-en-1-one (**1e**) {#sec4.2.5}

Yellow solid, 0.49 g, 76% yield. Mp: 75.7--76.9 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 14.53 (s, 1H), 7.95 (d, *J* = 12.4 Hz, 1H), 7.24--7.19 (m, 1H), 6.55 (dd, *J* = 8.0, 0.8 Hz, 1H), 6.35 (dd, *J* = 8.4, 0.8 Hz, 1H), 6.26 (d, *J* = 12.4 Hz, 1H), 3.86 (s, 3H), 3.16 (s, 3H), 2.93 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 190.8, 164.8, 160.2, 154.9, 133.3, 111.8, 111.1, 101.3, 97.7, 55.8, 45.4, 37.5. HRMS-ESI (*m*/*z*): Calculated for C~12~H~15~NO~3~ (M + H)^+^: 222.1130, Found: 222.1129.

### (*E*)-3-(Dimethylamino)-1-(2-hydroxy-5-methoxyphenyl)prop-2-en-1-one (**1f**)^[@ref14]^ {#sec4.2.6}

Yellow solid, 0.43 g, 68% yield. Mp: 103.1--104.1 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 13.41 (s, 1H), 7.87 (d, *J* = 12.4 Hz, 1H), 7.18 (d, *J* = 3.2 Hz, 1H), 6.99 (dd, *J* =8.8, 2.8 Hz, 1H), 6.87 (d, *J* = 8.8 Hz, 1H), 5.71 (d, *J* = 12.4 Hz, 1H), 3.79 (s, 3H), 3.18 (s, 3H), 2.96 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 191.2, 157.2, 155.0, 151.3, 120.7, 120.3, 118.8, 112.8, 90.1, 56.2, 45.6, 37.6.

### (*E*)-3-(Dimethylamino)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one (**1g**)^[@ref14]^ {#sec4.2.7}

Yellow solid, 0.55 g, 83% yield. Mp: 139.4--140.0 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 14.49 (s, 1H), 7.83 (d, *J* = 12.0 Hz, 1H), 7.60 (d, *J* = 8.8 Hz, 1H), 6.41 (d, *J* = 2.4 Hz, 1H), 6.37 (dd, *J* = 9.2, 2.8 Hz, 1H), 5.67 (d, *J* = 12.0 Hz, 1H), 3.81 (s, 3H), 3.16 (s, 3H), 2.94 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 190.6, 165.6, 164.3, 154.0, 129.7, 113.9, 106.4, 101.0, 89.8, 55.4, 45.3, 37.4.

### (*E*)-3-(Dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one (**1h**) {#sec4.2.8}

Yellow solid, 0.50 g, 90% yield. Mp: 142.5--143.5 ^o^C. ^1^H NMR (400 MHz, CDCl~3~): δ 15.65 (s, 1H), 7.91 (d, *J* = 12.4 Hz, 1H), 6.25 (d, *J* = 12.4 Hz, 1H), 6.06 (d, *J* = 2.4 Hz, 1H), 5.91 (d, *J* = 2.4 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 3.14 (s, 3H), 2.92 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 190.0, 167.9, 164.1, 161.7, 154.4, 105.4, 96.8, 94.0, 90.6, 55.7, 55.4, 45.3, 37.4. HRMS-ESI (*m*/*z*): Calculated for C~13~H~17~NO~4~ (M + H)^+^: 252.1236, Found: 252.1234.

### (*E*)-3-(Dimethylamino)-1-(2-hydroxy-5-methylphenyl)prop-2-en-1-one (**1i**)^[@ref14]^ {#sec4.2.9}

Yellow solid, 1.04 g, 80% yield. Mp: 136.2--137.1 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 13.72 (s, 1H), 7.87 (d, *J* = 12.0 Hz, 1H), 7.47 (d, *J* = 1.6 Hz, 1H), 7.17 (dd, *J* = 8.4, 2.0 Hz, 1H), 6.84 (d, *J* = 8.4 Hz, 1H), 5.77 (d, *J* = 12.0 Hz, 1H), 3.19 (s, 3H), 2.99 (s, 3H), 2.30 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 191.7, 160.9, 154.8, 135.1, 128.3, 127.0, 120.0, 118.1, 90.2, 45.5, 37.6, 20.8.

### (*E*)-3-(Dimethylamino)-1-(2-hydroxy-4-methylphenyl)prop-2-en-1-one (**1j**)^[@ref14]^ {#sec4.2.10}

Yellow solid, 0.80 g, 61% yield. Mp: 130.0--131.5 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 13.97 (s, 1H), 7.86 (d, *J* = 12.0 Hz, 1H), 7.57 (d, *J* = 8.0 Hz, 1H), 6.74 (s, 1H), 6.63 (dd, *J* = 8.0, 1.2 Hz, 1H), 5.74 (d, *J* = 12.0 Hz, 1H), 3.18 (s, 3H), 2.96 (s, 3H), 2.32 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 191.4, 191.3, 163.1, 154.6, 145.2, 128.3, 119.4, 118.5, 118.0, 90.1, 45.5, 37.5.

### (*E*)-1-(5-Chloro-2-hydroxy-4-methylphenyl)-3-(dimethylamino)prop-2-en-1-one (**1k**) {#sec4.2.11}

Yellow solid, 1.00 g, 80% yield. Mp: 180.8--181.9 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 13.87 (s, 1H), 7.85 (d, *J* = 12.4 Hz, 1H), 7.61 (s, 1H), 6.80 (s, 1H), 5.64 (d, *J* = 12.4 Hz, 1H), 3.18 (s, 3H), 2.96 (s, 3H), 2.32 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 190.1, 161.5, 155.1, 142.5, 128.1, 123.2, 120.3, 119.4, 89.8, 45.6, 37.6, 20.6. HRMS-ESI (*m*/*z*): Calculated for C~12~H~14~ClNO~2~ (M + H)^+^: 240.0791, Found: 240.0789.

### (*E*)-3-(3-(Dimethylamino)acryloyl)-4-hydroxybenzonitrile (**1l**)^[@ref14]^ {#sec4.2.12}

Brown solid, 0.30 g, 49% yield. Mp: 174.0--174.5 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 14.81 (s, 1H), 8.00 (d, *J* = 2.0 Hz, 1H), 7.94 (d, *J* = 12.0 Hz, 1H), 7.57 (dd, *J* = 8.8, 1.6 Hz, 1H), 6.97 (d, *J* = 8.4 Hz, 1H), 5.68 (d, *J* = 12.0 Hz, 1H), 3.25 (s, 3H), 3.04 (s, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 189.5, 166.8, 155.9, 136.6, 133.4, 120.7, 119.8, 119.4, 101.2, 89.3, 45.9, 37.9.

General Procedure for the Photoredox Reaction {#sec4.3}
---------------------------------------------

A mixture of *o*-hydroxyaryl enaminones (**1a**, 95.61 mg, 0.5 mmol), ethyl bromodifluoroacetate (253.73 mg, 1.25 mmol), Et~3~N (20.24 mg, 40 mol %), NaHSO~3~ (78.05 mg, 0.75 mmol), and Ru(bpy)~3~Cl~2~ (4.70 mg, 1 mol %) in DMSO (6 mL) in a sealed 25 mL Schlenk tube was irradiated with a 45 W LED light bulb at room temperature for 24 h under a N~2~ atmosphere. After the reaction was completed, the resulting mixture was diluted with 30 mL of H~2~O and extracted with EA (3 × 10 mL). The combined organic phases were dried over anhydrous Na~2~SO~4~ and concentrated under vacuum. The resulting residue was purified using flash column chromatography on silica gel with EA/PE (1/10) to afford the desired product, **2a**.

### Ethyl 2,2-Difluoro-2-(4-oxo-4*H*-chromen-3-yl)acetate (**2a**)^[@cit8b]^ {#sec4.3.1}

White solid, 108.6 mg, 81% yield. Mp: 89.0--90.6 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.33--8.30 (m, 1H), 8.20 (dd, *J* = 8.0, 0.4 Hz, 1H), 7.78--7.71 (m, 1H), 7.53 (d, *J* = 8.4 Hz, 1H), 7.49--7.44 (m, 1H), 4.39 (q, *J* = 7.2 Hz, 2H), 1.35 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 174.7 (t, *J* = 3.3 Hz), 162.8 (d, *J* = 32.1 Hz), 156.4, 155.2 (t, *J* = 9.6 Hz), 134.9, 126.3, 126.0, 123.9, 119.0 (t, *J* = 22.4 Hz), 118.5, 111.5 (t, *J* = 248.9 Hz), 63.5, 14.0. ^19^F NMR (376 MHz, CDCl~3~): δ −29.5.

### Ethyl 2,2-Difluoro-2-(5-fluoro-4-oxo-4*H*-chromen-3-yl)acetate (**2b**) {#sec4.3.2}

Yellow solid, 93.0 mg, 65% yield. Mp: 55.4--57.4 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.25--8.22 (m, 1H), 7.71--7.64 (m, 1H), 7.34 (dd, *J* = 8.4, 0.8 Hz, 1H), 7.14--7.08 (m, 1H), 4.38 (q, *J* = 7.2 Hz, 2H), 1.35 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 172.9 (t, *J* = 3.3 Hz), 162.5 (t, *J* = 32.0 Hz), 160.7 (d, *J* = 265.5 Hz), 157.2 (d, *J* = 3.4 Hz), 154.4 (t, *J* = 9.7 Hz), 153.0, 135.0 (d, *J* = 10.7 Hz), 120.0 (t, *J* = 22.7 Hz), 114.4 (d, *J* = 4.6 Hz), 113.2 (d, *J* = 20.2 Hz), 111.2 (t, *J* = 249.1 Hz), 63.6, 14.0. ^19^F NMR (376 MHz, CDCl~3~): δ −29.4, −35.4. HRMS-ESI (*m*/*z*): Calculated for C~13~H~9~F~3~O~4~ (M + H)^+^: 287.0531, Found: 287.0531.

### Ethyl 2,2-Difluoro-2-(6-fluoro-4-oxo-4*H*-chromen-3-yl)acetate (**2c**)^[@cit8b]^ {#sec4.3.3}

White solid, 86.0 mg, 60% yield. Mp: 103.0--104.1 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.33--8.31 (m, 1H), 7.80 (dd, *J* = 8.0, 3.2 Hz, 1H), 7.56 (dd, *J* = 9.2, 4.0 Hz, 1H), 7.49--7.43 (m, 1H), 4.37 (q, *J* = 7.2 Hz, 2H), 1.34 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 173.9 (t, *J* = 3.2 Hz), 162.6 (t, *J* = 32.3 Hz), 160.1 (d, *J* = 247.4 Hz), 155.4 (t, *J* = 9.6 Hz), 152.6 (d, *J* = 1.8 Hz), 125.1 (d, *J* = 7.6 Hz), 123.1 (d, *J* = 25.3 Hz), 120.8 (d, *J* = 8.2 Hz), 118.4 (t, *J* = 22.5 Hz), 111.3 (t, *J* = 249.1 Hz), 110.8 (d, *J* = 23.9 Hz), 63.6, 14.0. ^19^F NMR (376 MHz, CDCl~3~): δ −29.4, −35.4.

### Ethyl 2,2-Difluoro-2-(7-fluoro-4-oxo-4*H*-chromen-3-yl)acetate (**2d**)^[@cit8b]^ {#sec4.3.4}

White solid, 113.0 mg, 79% yield. Mp: 67.4--68.5 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.30--8.26 (m, 1H), 8.18 (dd, *J* = 8.8, 6.0 Hz, 1H), 7.22--7.14 (m, 2H), 4.36 (q, *J* = 7.2 Hz, 2H), 1.33 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 173.6 (t, *J* = 3.2 Hz), 166.1 (d, *J* = 255.7 Hz), 162.5 (t, *J* = 32.2 Hz), 157.4 (d, *J* = 13.3 Hz), 155.4 (t, *J* = 9.5 Hz), 128.5 (d, *J* = 10.6 Hz), 120.7, 119.1 (t, *J* = 22.4 Hz), 115.2 (d, *J* = 22.8 Hz), 111.2 (t, *J* = 249.2 Hz), 105.3 (d, *J* = 25.4 Hz), 63.5, 13.9. ^19^F NMR (376 MHz, CDCl~3~): δ −24.1, −30.2.

### Ethyl 2,2-Difluoro-2-(5-methoxy-4-oxo-4*H*-chromen-3-yl)acetate (**2e**)^[@cit8b]^ {#sec4.3.5}

Yellow solid, 95.6 mg, 80% yield. Mp: 89.7--91.2 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.14--8.11 (m, 1H), 7.62--7.58 (m, 1H), 7.06 (dd, *J* = 8.4, 0.8 Hz, 1H), 6.85 (d, *J* = 8.4 Hz, 1H), 4.38 (q, *J* = 7.2 Hz, 2H), 3.96 (s, 3H), 1.34 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 174.4 (t, *J* = 3.3 Hz), 162.7 (t, *J* = 32.2 Hz), 160.2, 158.4, 153.4 (t, *J* = 9.9 Hz), 134.9, 120.2 (t, *J* = 22.4 Hz), 114.5, 111.6 (t, *J* = 248.2 Hz), 110.2, 107.4, 63.3, 56.7, 14.0. ^19^F NMR (376 MHz, CDCl~3~): δ −30.2.

### Ethyl 2,2-Difluoro-2-(6-methoxy-4-oxo-4*H*-chromen-3-yl)acetate (**2f**)^[@cit8b]^ {#sec4.3.6}

White solid, 47.7 mg, 40% yield. Mp: 86.6--87.3 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.31--8.30 (m, 1H), 7.54 (d, *J* = 3.2 Hz, 1H), 7.47 (d, *J* = 9.2 Hz, 1H), 7.32 (dd, *J* = 9.2, 2.8 Hz, 1H), 4.39 (q, *J* = 7.2 Hz, 2H), 3.88 (s, 3H), 1.36 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 174.6 (t, *J* = 3.3 Hz), 162.8 (t, *J* = 32.3 Hz), 157.7, 154.9 (t, *J* = 9.6 Hz), 151.3, 124.9, 124.6, 119.9, 118.2 (t, *J* = 22.4 Hz), 111.6 (t, *J* = 248.7 Hz), 104.9, 63.5, 56.1, 14.0. ^19^F NMR (376 MHz, CDCl~3~): δ −29.3.

### Ethyl 2,2-Difluoro-2-(6-methoxy-4-oxo-4*H*-chromen-3-yl)acetate (**2g**)^[@cit8b]^ {#sec4.3.7}

White solid, 74.0 mg, 62% yield. Mp: 70.9--72.5 °C. ^1^H NMR (400 MHz, CDCl~3~): ^1^H NMR (400 MHz, CDCl~3~) δ 8.23--8.22 (m, 1H), 8.07 (d, *J* = 9.2 Hz, 1H), 7.00 (dd, *J* = 8.8, 2.4 Hz, 1H), 6.89 (d, *J* = 2.4 Hz, 1H), 4.38 (q, *J* = 7.2 Hz, 2H), 3.90 (s, 3H), 1.34 (t, *J* = 7.2 Hz, 3H).^13^C {^1^H} NMR (100 MHz, CDCl~3~): ^13^C NMR (101 MHz, CDCl~3~) δ 173.9 (t, *J* = 3.3 Hz), 164.9, 162.8 (t, *J* = 32.3 Hz), 158.2, 154.7 (t, *J* = 9.7 Hz), 127.2, 118.8 (t, *J* = 22.2 Hz), 117.6, 115.5, 111.5 (t, *J* = 248.6 Hz), 100.6, 63.4, 56.1, 13.9. ^19^F NMR (376 MHz, CDCl~3~): δ −29.4.

### Ethyl 2-(5,7-Dimethoxy-4-oxo-4*H*-chromen-3-yl)-2,2-difluoroacetate (**2h**) {#sec4.3.8}

White solid, 107.7 mg, 82% yield. Mp: 111.4--112.5 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.04 (s, 1H), 6.44 (d, *J* = 2.4 Hz, 1H), 6.34 (d, *J* = 2.4 Hz, 1H), 4.33 (q, *J* = 7.2 Hz, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 1.30 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 173.4 (t, *J* = 3.3 Hz), 164.8, 162.7 (t, *J* = 32.3 Hz), 161.2, 159.9, 152.8 (t, *J* = 10.0 Hz), 119.9 (t, *J* = 22.2 Hz), 111.6 (t, *J* = 247.9 Hz), 109.0, 96.8, 93.0, 63.2, 56.5, 55.9, 13.9. ^19^F NMR (376 MHz, CDCl~3~): δ −30.2. HRMS-ESI (*m*/*z*): Calculated for C~15~H~14~F~2~NO~6~ (M + H)^+^: 329.0837, Found: 329.0831.

### Ethyl 2,2-Difluoro-2-(6-methyl-4-oxo-4*H*-chromen-3-yl)acetate (**2i**)^[@cit8b]^ {#sec4.3.9}

White solid, 73.4 mg, 52% yield. Mp: 37.1--38.4 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.30--8.29 (m, 1H), 7.97 (d, *J* = 1.2 Hz, 1H), 7.54 (dd, *J* = 8.8, 2.0 Hz, 1H), 7.41 (d, *J* = 8.8 Hz, 1H), 4.38 (q, *J* = 7.2 Hz, 2H), 2.45 (s, 3H), 1.35 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 174.7 (t, *J* = 3.2 Hz), 162.8 (t, *J* = 32.4 Hz), 155.1 (t, *J* = 9.6 Hz), 154.7, 136.5, 136.0, 125.2, 123.6, 118.7 (t, *J* = 22.3 Hz), 118.2, 111.5 (t, *J* = 248.6 Hz), 63.5, 21.1, 14.0. ^19^F NMR (376 MHz, CDCl~3~): δ −29.4.

### Ethyl 2,2-Difluoro-2-(7-methyl-4-oxo-4*H*-chromen-3-yl)acetate (**2j**)^[@cit8a]^ {#sec4.3.10}

White solid, 103.0 mg, 73% yield. Mp: 116.9--118.3 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.29--8.27 (m, 1H), 8.06 (d, *J* = 8.4 Hz, 1H), 7.30 (d, *J* = 13.2 Hz, 2H), 4.39 (q, *J* = 7.2 Hz, 2H), 2.51 (s, 3H), 1.35 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 174.5 (t, *J* = 3.3 Hz), 162.8 (t, *J* = 32.4 Hz), 156.5, 155.0 (t, *J* = 9.7 Hz), 146.5, 127.7, 125.6, 121.6, 118.8 (t, *J* = 22.3 Hz), 118.1, 111.5 (t, *J* = 248.7 Hz), 63.4, 22.0, 13.9. ^19^F NMR (376 MHz, CDCl~3~): δ −29.4.

### Ethyl 2-(6-Chloro-7-methyl-4-oxo-4*H*-chromen-3-yl)-2,2-difluoroacetate (**2k**)^[@cit8a]^ {#sec4.3.11}

White solid, 87.4 mg, 69% yield. Mp: 117.9--118.9 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.27--8.25 (m, 1H), 8.10 (s, 1H), 7.41 (s, 1H), 4.37 (q, *J* = 7.2 Hz, 2H), 2.50 (s, 3H), 1.34 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 173.5 (t, *J* = 3.2 Hz), 162.6 (t, *J* = 32.2 Hz), 155.2 (t, *J* = 9.6 Hz), 154.6, 144.4, 133.1, 125.5, 122.9, 120.3, 118.8 (t, *J* = 22.5 Hz), 111.3 (t, *J* = 249.1 Hz), 63.6, 21.0, 14.0. ^19^F NMR (376 MHz, CDCl~3~): δ −29.4.

### Ethyl 2-(6-Cyano-4-oxo-4*H*-chromen-3-yl)-2,2-difluoroacetate (**2l**) {#sec4.3.12}

White solid, 96.8 mg, 66% yield. Mp: 105.5--106.7 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 8.52 (d, *J* = 2.4 Hz, 1H), 8.35 (s, 1H), 7.97 (dd, *J* = 8.8, 2.0 Hz, 1H), 7.67 (d, *J* = 8.8 Hz, 1H), 4.40 (q, *J* =6.8 Hz, 2H), 1.36 (t, *J* = 7.2 Hz, 3H). ^13^C {^1^H} NMR (100 MHz, CDCl~3~): δ 172.8 (t, *J* = 3.2 Hz), 162.2 (t, *J* = 32.0 Hz), 158.0, 155.6 (t, *J* = 9.7 Hz), 137.1, 131.4, 124.3, 120.3, 119.9 (t, *J* = 22.9 Hz), 117.1, 110.7, 111.0 (t, *J* = 250.0 Hz), 63.7, 13.9. ^19^F NMR (376 MHz, CDCl~3~) δ: −29.7. HRMS-ESI (*m*/*z*): Calculated for C~15~H~14~F~2~NO~6~ (M + H)^+^: 294.0587, Found: 294.0585.
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